Literature DB >> 25459672

Inflammatory breast cancer: an overview.

D J P van Uden1, H W M van Laarhoven2, A H Westenberg3, J H W de Wilt4, C F J M Blanken-Peeters5.   

Abstract

Inflammatory breast cancer (IBC) is the most aggressive entity of breast cancer. Management involves coordination of multidisciplinary management and usually includes neoadjuvant chemotherapy, ablative surgery if a tumor-free resection margin is expected and locoregional radiotherapy. This multimodal therapeutic approach has significantly improved patient survival. However, the median overall survival among women with IBC is still poor. By elucidating the biologic characteristics of IBC, new treatment options may become available. We performed a comprehensive review of the English-language literature on IBC through computerized literature searches. The objective of the current review is to present an overview of the literature related to the biology, imaging and multidisciplinary treatment of inflammatory breast cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Inflammatory breast cancer; Molecular characteristics; Surgery; Treatment

Mesh:

Substances:

Year:  2014        PMID: 25459672     DOI: 10.1016/j.critrevonc.2014.09.003

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  37 in total

1.  Breast cancer histologic subtypes show excess familial clustering.

Authors:  N Lynn Henry; Lisa A Cannon-Albright
Journal:  Cancer       Date:  2019-05-23       Impact factor: 6.860

2.  Gold Nanoparticles Doped with (199) Au Atoms and Their Use for Targeted Cancer Imaging by SPECT.

Authors:  Yongfeng Zhao; Bo Pang; Hannah Luehmann; Lisa Detering; Xuan Yang; Deborah Sultan; Scott Harpstrite; Vijay Sharma; Cathy S Cutler; Younan Xia; Yongjian Liu
Journal:  Adv Healthc Mater       Date:  2016-02-10       Impact factor: 9.933

Review 3.  Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy.

Authors:  Sachin Kumar Deshmukh; Sanjeev Kumar Srivastava; Teja Poosarla; Donna Lynn Dyess; Nicolette Paolaungthong Holliday; Ajay Pratap Singh; Seema Singh
Journal:  Ann Transl Med       Date:  2019-10

4.  Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade.

Authors:  Chiara Secondini; Oriana Coquoz; Lorenzo Spagnuolo; Thibaud Spinetti; Sanam Peyvandi; Laura Ciarloni; Francesca Botta; Carole Bourquin; Curzio Rüegg
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

5.  Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.

Authors:  Catherine Schairer; Ahmed Hablas; Ibrahim AbdelBar Seif Eldein; Rabab Gaafar; Henda Rais; Amel Mezlini; Farhat Ben Ayed; Wided Ben Ayoub; Abdellatif Benider; Ali Tahri; Mouna Khouchani; Dalia Aboulazm; Mehdi Karkouri; Saad Eissa; Ruth M Pfeiffer; Shahinaz M Gadalla; Sandra M Swain; Sofia D Merajver; Linda Morris Brown; Amr S Soliman
Journal:  Breast Cancer Res Treat       Date:  2019-04-22       Impact factor: 4.872

6.  Inflammatory Breast Cancer at the Extremes of Age.

Authors:  Taiwo Adesoye; Oluwatowo Babayemi; Lauren M Postlewait; Sarah M DeSnyder; Susie X Sun; Wendy A Woodward; Naoto T Ueno; Kelly K Hunt; Anthony Lucci; Mediget Teshome
Journal:  Ann Surg Oncol       Date:  2021-07-22       Impact factor: 5.344

7.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Inflammatory Breast Cancer Prior to and After Neoadjuvant Treatment.

Authors:  Dominique J P van Uden; J Hans W de Wilt; Carla Meeuwis; Charlotte F J M Blanken-Peeters; Ritse M Mann
Journal:  Breast Care (Basel)       Date:  2017-08-29       Impact factor: 2.860

8.  Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.

Authors:  Oluwadamilola M Fayanju; Yi Ren; Rachel A Greenup; Jennifer K Plichta; Laura H Rosenberger; Jeremy Force; Gita Suneja; Gayathri R Devi; Tari A King; Faina Nakhlis; Terry Hyslop; E Shelley Hwang
Journal:  Breast Cancer Res Treat       Date:  2020-01-20       Impact factor: 4.872

9.  Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer.

Authors:  Neha Aggarwal; Ann Marie Santiago; David Kessel; Bonnie F Sloane
Journal:  Breast Cancer Res Treat       Date:  2015-10-26       Impact factor: 4.872

10.  Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016.

Authors:  Daniel I Hoffman; Patricia Mae G Santos; Macy Goldbach; Luke J Keele; Neil K Taunk; Hannah S Bogen; Laura Burkbauer; Rachel C Jankowitz; Joshua Fosnot; Liza C Wu; Gary M Freedman; Julia C Tchou
Journal:  Ann Surg Oncol       Date:  2021-07-16       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.